Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria Antista"'
Autor:
Alessandra Raimondi, Vincenzo Adamo, Roberto Murialdo, Patrizia Racca, Filippo de Braud, Monica Niger, Valeria Smiroldo, Marco Tampellini, Fausto Petrelli, Monica Giordano, Chiara Cremolini, Alberto Zaniboni, Saverio Cinieri, Matteo Clavarezza, Federica Morano, Alfredo Falcone, Marta Caporale, Rosa Berenato, Vittorina Zagonel, Salvatore Corallo, Francesca Bergamo, Filippo Pietrantonio, Andrea Sartore-Bianchi, Maria Di Bartolomeo, Gianluca Tomasello, Rosalba Miceli, Maria Antista, Sara Lonardi, Raffaella Longarini, Lorenza Rimassa
Importance Few studies are available on the role of maintenance strategies after induction treatment regimens based on anti–epidermal growth factor receptors, and the optimal regimen for an anti–epidermal growth factor receptors–based maintenan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb9fd0d9893386f50df6c7cda317d22
http://hdl.handle.net/11570/3169569
http://hdl.handle.net/11570/3169569
Autor:
Marta Caporale, Salvatore Corallo, Alberto Gianluigi Luporini, Andrea Spallanzani, Michele Basso, Maria Di Bartolomeo, Mario Scartozzi, Federica Morano, Evaristo Maiello, Davide Tassinari, Andrea Bonetti, Graziella Pinotti, Filippo de Braud, Saverio Cinieri, Sergio Bracarda, Giovanni Gerardo Cardellino, Alessandro Bertolini, Claudio Verusio, Gianluca Tomasello, Hector Soto Parra, Alberto Zaniboni, Giampaolo Tortora, Samantha Di Donato, Sara Lonardi, Vincenzo Catalano, Francesco Di Costanzo, Raffaella Longarini, Libero Ciuffreda, Ferdinando De Vita, Francesco Giuliani, Maria Antista, Lorenza Rimassa, Rossana Berardi, Filippo Pietrantonio, Monica Niger, Stefano Tamberi, Lorenzo Fornaro, Giorgio V. Scagliotti, Giovanni Luca Frassineti
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer
BMC Cancer
Platinum/fluoropyrimidine regimens are the backbone of first-line chemotherapy for advanced gastric cancer (AGC). However response rates to first line chemotherapy range from 30 to 50% and disease progression occurs after 4–6 cycles. The optimal du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dafc3b1c542b0f3d4e69272eb1e8208d
http://hdl.handle.net/11591/423436
http://hdl.handle.net/11591/423436
Autor:
Shigeki Kusamura, Federica Morano, Federica Marmorino, Marcello Deraco, Chiara Cremolini, Massimo Milione, Marcello Guaglio, Filippo de Braud, Dario Baratti, Alessandra Raimondi, Maria Antista, Giovanni Randon, Salvatore Corallo, Maria Di Bartolomeo, Filippo Pietrantonio, Monica Niger
Background No standard treatment for advanced unresectable pseudomyxoma peritonei (PMP) has been defined so far. PMP is traditionally considered chemoresistant but nonrandomized series showed promising results with regimens for gastrointestinal tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc264c2ff9dd0cd9b6b2fdf37fa1e18
http://hdl.handle.net/11568/994222
http://hdl.handle.net/11568/994222
Autor:
Chiara Cremolini, F. Perrone, Federico Nichetti, Luigi Battaglia, Giancarlo Pruneri, Alessandra Raimondi, A. Martinetti, Rosa Berenato, Massimo Milione, F. de Braud, M. Di Bartolomeo, Alfredo Falcone, Monica Niger, F. Di Nicolantonio, Giovanni Randon, Roberto Moretto, Federica Morano, Maria Antista, Filippo Pietrantonio, A. Belfiore, Salvatore Corallo, Ludovic Barault
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 29(8)
Background Non-randomized studies showed that temozolomide (TMZ) achieves an average 10% response rate in heavily pretreated metastatic colorectal cancer (mCRC) patients with promoter methylation of the DNA repair gene O6-methylguanine-DNA methyltran
Autor:
Alessandra Raimondi, Maria Antista, Jorgelina Coppa, Alessia Mennitto, Luigi Mariani, Salvatore Lo Vullo, Filippo de Braud, Michele Droz dit Busset, Giovanni Fucà, Filippo Pietrantonio, Federica Perrone, Michele Prisciandaro, Alessandra Alessi, Christian Cotsoglou, Vincenzo Mazzaferro, Federico Nichetti, Massimo Milione, Federica Morano, Antonino Belfiore, Giovanni Randon, Barbara Padovano, Marta Vaiani, Silvia Lazzati, Salvatore Corallo, Maria Di Bartolomeo
Publikováno v:
Clinical colorectal cancer. 18(1)
Background In colorectal cancer liver metastases (CRCLM), bevacizumab-based neoadjuvant strategies provide increased pathologic response. We aimed at assessing the activity of perioperative capecitabine, oxaliplatin, irinotecan, and bevacizumab (COI-
Autor:
Chiara Cremolini, Giovanni Fucà, Rosa Berenato, Monica Niger, Giovanni Randon, Alfredo Falcone, Antonino Belfiore, Francesca Vita, Filippo Pietrantonio, Maria Antista, Federica Perrone, Federico Nichetti, Federica Di Nicolantonio, Massimo Milione, Roberto Moretto, Alessandra Raimondi, Salvatore Corallo, Maria Di Bartolomeo, Federica Morano, Filippo de Braud, Giancarlo Pruneri, Ludovic Barault
Publikováno v:
Cancer Research. 78:CT095-CT095
Backgroud Metastatic colorectal cancer (mCRC) pts bearing promoter methylation of the DNA repair gene, O-6-methylguanine-DNA methyltransferase (MGMT), are suitable for treatment with temozolomide (TMZ) with an expected response rate up to 10% even in